NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 159 filers reported holding NUVALENT INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $991,000 | +24.2% | 13,063 | +22.9% | 0.00% | – |
| Q1 2024 | $798,000 | +3.5% | 10,627 | +1.4% | 0.00% | – |
| Q4 2023 | $771,000 | +458.7% | 10,484 | +249.1% | 0.00% | – |
| Q3 2023 | $138,000 | +112.3% | 3,003 | +95.9% | 0.00% | – |
| Q2 2023 | $65,000 | +124.1% | 1,533 | +35.1% | 0.00% | – |
| Q1 2023 | $29,000 | -65.1% | 1,135 | -59.2% | 0.00% | – |
| Q4 2022 | $83,000 | +1975.0% | 2,782 | +1250.5% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 206 | +116.8% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 95 | -91.6% | 0.00% | – |
| Q1 2022 | $16,000 | -64.4% | 1,125 | -51.8% | 0.00% | – |
| Q4 2021 | $45,000 | +55.2% | 2,335 | +82.0% | 0.00% | – |
| Q3 2021 | $29,000 | – | 1,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $843,021,482 | 18.00% |
| Fairmount Funds Management LLC | 2,884,492 | $121,639,028 | 17.15% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $150,853,349 | 15.54% |
| COMMODORE CAPITAL LP | 1,150,000 | $48,495,500 | 5.45% |
| Paradigm Biocapital Advisors LP | 1,120,465 | $47,250,009 | 3.65% |
| Perceptive Advisors | 2,194,821 | $92,555,602 | 2.68% |
| Boxer Capital, LLC | 1,210,192 | $51,034 | 2.37% |
| Ikarian Capital, LLC | 272,752 | $11,501,952 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 115,067 | $4,852,375 | 1.50% |
| HighVista Strategies LLC | 72,298 | $3,048,807 | 1.40% |